Clinical Trial Update: Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for recurrent abdominal pain and exocrine pancreatic insufficiency was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Pain
• Irritable Bowel Syndrome

Snippet

Sponsor: Orlando Health, Inc. | Conditions: Abdominal Pain, Irritable Bowel Syndrome | Phase 3 | Status: TERMINATED